Partners HealthCare has co-led a series A round for ZielBio to drive forward the development of a cancer treatment based on research at University of Virginia.
Author: Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
Phytelligence wilts away
Cowles-backed Phytelligence has lost its legal case with Washington State University, leaving the board with no option but to close its crop cultivation business.
Qi An Xin programs $210m round
Red Star Macaline has contributed to a $210m pre-IPO round for cybersecurity software producer Qi An Xin, which was spun off from Qihoo 360 in 2016.
DT Dream wakes up to $84m series B
Alibaba-backed cloud services provider DT Dream raised $84m in a series B round that reportedly boosted its valuation to $1.5bn.
Meissa synthesises $30m series A
Morningside Ventures has led a $30m series A round for Emory University spinout Meissa Vaccines, a current resident at Johnson & Johnsons’ JLabs incubator.
Divvy ups funding game with $43m
Divvy, which facilitates the progressive purchase of a home by using part of the rent for a future down payment, raised $43m in a series B round co-led by Lennar.
Spire Global points corporates to $40m series D
Itochu, Mitsui and Qualcomm Ventures were among the investors that supplied series D funding to weather nanosatellite developer Spire Global.
Panache styles final close for first fund
Panache Ventures has closed its inaugural fund at $43.7m thanks to limited partners including Telus, helping the vehicle overshoot its target by almost 50%.
Tulip unfolds series B round
DMG Mori, an existing customer of manufacturing app development platform Tulip, has contributed to a round that closed at $39.5m, alongside Vertex Ventures, NEA and Pitango.
Base prepares for Tokyo Stock Exchange jump
CyberAgent, Marui, Mercari and Money Forward are all in line for exits after e-commerce technology provider Base received approval for its initial public offering.
SEC gets Kik out of messaging space
Tencent-backed Kik is closing its social media and messaging app as it pursues a costly legal battle with the Securities and Exchange Commission over an initial coin offering.
Facebook punches in up to $1bn for Ctrl-Labs
Facebook has paid a reported $500m to $1bn to acquire neural interface technology developer Ctrl-Labs, which had raised $67m from investors including GV and Alexa Fund.
Tencent takes funding to ETechAces at $1.5bn valuation
Tencent has reportedly committed between $130m and $150m to ETechAces, a financial comparison service already backed by SoftBank Vision Fund and Info Edge.
Themis tackles $44m series D round
Merck & Co has contributed to Themis’ series D round after signing a strategic partnership agreement last month to develop vaccines for undisclosed diseases.